SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-022689
Filing Date
2014-01-28
Accepted
2014-01-27 19:19:54
Documents
3
Period of Report
2014-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d663041d8k.htm 8-K 18149
2 EX-1.1 d663041dex11.htm EX-1.1 168554
3 EX-5.1 d663041dex51.htm EX-5.1 6226
  Complete submission text file 0001193125-14-022689.txt   194252
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 14550274
SIC: 2834 Pharmaceutical Preparations